Reference priceEUR €63.11Original source price: INR 5,737.50. Converted estimates are available by currency selection.
| Brand | Medicamen Biotech Ltd |
|---|---|
| Manufacturer | Medicamen Biotech Ltd |
| Prescription required | Yes |
Borzomed 3.5mg Injection
Bortezomib (3.5mg)
Description
Borzomed 3.5mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant.Benefits
Uses of Borzomed Injection 1.Multiple myeloma 2.Mantle-cell lymphomaHow to Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.Specification
Your doctor or nurse will give you this medicine. Kindly do not self administer.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Borzomed Fungal infection Anemia (low number of red blood cells) Breathlessness Decreased white blood cell count (neutrophils) Dehydration High blood pressure Itching Erythema (skin redness) Gastrointestinal bleeding Herpes zoster Pneumonia Motor neuropathy Orthostatic hypotension (sudden lowering of blood pressure on standing) Dry skin Edema (swelling) Low blood plateletsDiese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.